MedTrace Logo

Impact of CASP3 Gene in Chemoresistance

NCT06195371 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-02-28

No results posted yet for this study

Summary

1. This study aims to evaluate the abnormalities of CASP3 gene in chemo resistance in breast cancer by FISH technique. evaluate the abnormalities of CASP3 gene in chemo resistance in breast cancer by FISH technique.
2. Detect CASP3 gene abnormality relation to survival, chemoresponse \& chemoresistance.
3. Correlate CASP3 gene abnormalities with available clinicopathological data of breast cancer patients.

Conditions

Sponsors & Collaborators

  • Assiut University

    collaborator OTHER

  • Gehad Salah El-Din shaker

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2026-11-30
Completion
2026-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06195371 on ClinicalTrials.gov